| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| European Union | 23 | 2021 | 565 | 4.17 | Why? |
| Health Policy | 39 | 2021 | 6242 | 3.31 | Why? |
| Politics | 21 | 2021 | 1824 | 3.12 | Why? |
| Economic Recession | 9 | 2020 | 453 | 2.59 | Why? |
| State Medicine | 17 | 2021 | 2847 | 2.54 | Why? |
| Tobacco Industry | 3 | 2019 | 45 | 1.94 | Why? |
| Undocumented Immigrants | 3 | 2018 | 100 | 1.87 | Why? |
| Public Health | 26 | 2021 | 16359 | 1.72 | Why? |
| Delivery of Health Care | 21 | 2021 | 15909 | 1.59 | Why? |
| Food Supply | 5 | 2020 | 1027 | 1.50 | Why? |
| United Kingdom | 44 | 2021 | 18046 | 1.48 | Why? |
| Foundations | 2 | 2019 | 88 | 1.40 | Why? |
| Commerce | 8 | 2021 | 1109 | 1.37 | Why? |
| Industry | 3 | 2021 | 347 | 1.33 | Why? |
| Government Programs | 4 | 2021 | 512 | 1.33 | Why? |
| Early Detection of Cancer | 5 | 2018 | 1956 | 1.32 | Why? |
| Conflict of Interest | 3 | 2018 | 175 | 1.30 | Why? |
| International Cooperation | 10 | 2021 | 3436 | 1.28 | Why? |
| Reimbursement Mechanisms | 2 | 2019 | 243 | 1.27 | Why? |
| Investments | 5 | 2020 | 166 | 1.26 | Why? |
| Agriculture | 2 | 2020 | 367 | 1.22 | Why? |
| Emigration and Immigration | 4 | 2020 | 501 | 1.21 | Why? |
| Environmental Pollution | 2 | 2019 | 344 | 1.18 | Why? |
| Mortality | 13 | 2020 | 7132 | 1.17 | Why? |
| Europe | 31 | 2021 | 12702 | 1.11 | Why? |
| Transients and Migrants | 6 | 2021 | 1468 | 1.11 | Why? |
| Pediatric Obesity | 3 | 2018 | 492 | 1.08 | Why? |
| Social Welfare | 4 | 2019 | 141 | 1.07 | Why? |
| Research Support as Topic | 3 | 2018 | 327 | 1.05 | Why? |
| National Health Programs | 3 | 2020 | 807 | 1.04 | Why? |
| Drugs, Essential | 3 | 2021 | 117 | 1.04 | Why? |
| Emigrants and Immigrants | 3 | 2018 | 888 | 1.03 | Why? |
| Drug Industry | 3 | 2021 | 689 | 1.00 | Why? |
| Life Expectancy | 6 | 2021 | 474 | 1.00 | Why? |
| Uterine Cervical Neoplasms | 4 | 2018 | 842 | 0.99 | Why? |
| Government | 6 | 2021 | 1453 | 0.98 | Why? |
| Roma | 3 | 2017 | 61 | 0.97 | Why? |
| Carbonated Beverages | 3 | 2019 | 45 | 0.94 | Why? |
| Public Health Administration | 3 | 2020 | 846 | 0.93 | Why? |
| Energy Intake | 3 | 2019 | 323 | 0.91 | Why? |
| Smoking Prevention | 4 | 2017 | 116 | 0.89 | Why? |
| Purchasing, Hospital | 1 | 2020 | 3 | 0.88 | Why? |
| Global Burden of Disease | 3 | 2020 | 531 | 0.88 | Why? |
| Food Industry | 3 | 2018 | 197 | 0.88 | Why? |
| Health Services Accessibility | 14 | 2020 | 10697 | 0.87 | Why? |
| Electronic Mail | 2 | 2018 | 102 | 0.85 | Why? |
| Negotiating | 1 | 2020 | 46 | 0.81 | Why? |
| Social Conformity | 1 | 2019 | 12 | 0.80 | Why? |
| Propaganda | 1 | 2019 | 22 | 0.79 | Why? |
| Alcoholic Beverages | 4 | 2019 | 186 | 0.78 | Why? |
| Licensure | 1 | 2021 | 144 | 0.78 | Why? |
| Demography | 4 | 2021 | 1660 | 0.78 | Why? |
| Orphan Drug Production | 1 | 2019 | 31 | 0.77 | Why? |
| Hospital Administrators | 1 | 2019 | 50 | 0.77 | Why? |
| Health Systems Plans | 2 | 2018 | 56 | 0.77 | Why? |
| Professional Role | 3 | 2019 | 1280 | 0.76 | Why? |
| Coca | 1 | 2018 | 3 | 0.76 | Why? |
| Humans | 202 | 2021 | 930598 | 0.75 | Why? |
| Government Agencies | 1 | 2021 | 248 | 0.75 | Why? |
| Nutrition Policy | 1 | 2020 | 132 | 0.75 | Why? |
| Food | 2 | 2018 | 316 | 0.75 | Why? |
| Financial Support | 3 | 2020 | 170 | 0.74 | Why? |
| Russia | 15 | 2019 | 989 | 0.74 | Why? |
| Human Rights | 6 | 2019 | 618 | 0.73 | Why? |
| Community-Based Participatory Research | 1 | 2020 | 271 | 0.72 | Why? |
| Flavoring Agents | 1 | 2017 | 20 | 0.71 | Why? |
| Health Expenditures | 4 | 2021 | 904 | 0.71 | Why? |
| England | 13 | 2020 | 5116 | 0.71 | Why? |
| Fees and Charges | 1 | 2017 | 27 | 0.70 | Why? |
| Taxes | 1 | 2018 | 66 | 0.70 | Why? |
| Global Health | 16 | 2021 | 13911 | 0.70 | Why? |
| Financial Management | 1 | 2018 | 65 | 0.69 | Why? |
| Off-Label Use | 2 | 2019 | 553 | 0.69 | Why? |
| Compassionate Use Trials | 2 | 2019 | 632 | 0.69 | Why? |
| Policy Making | 5 | 2018 | 829 | 0.69 | Why? |
| Developing Countries | 8 | 2021 | 4283 | 0.67 | Why? |
| Terrorism | 1 | 2018 | 92 | 0.67 | Why? |
| Health Services | 3 | 2018 | 765 | 0.66 | Why? |
| Fee-for-Service Plans | 1 | 2017 | 144 | 0.65 | Why? |
| Tobacco Products | 2 | 2019 | 245 | 0.64 | Why? |
| Democracy | 1 | 2017 | 63 | 0.64 | Why? |
| Population Health | 2 | 2020 | 504 | 0.64 | Why? |
| Physician Executives | 1 | 2017 | 71 | 0.63 | Why? |
| Organizational Policy | 2 | 2020 | 694 | 0.63 | Why? |
| Decision Making | 3 | 2021 | 3132 | 0.62 | Why? |
| Fires | 1 | 2017 | 87 | 0.62 | Why? |
| Quality Improvement | 3 | 2020 | 2435 | 0.62 | Why? |
| Public Sector | 1 | 2018 | 204 | 0.62 | Why? |
| Colorectal Neoplasms | 3 | 2018 | 1884 | 0.62 | Why? |
| Drugs, Generic | 1 | 2017 | 136 | 0.61 | Why? |
| Longevity | 1 | 2017 | 159 | 0.60 | Why? |
| Healthcare Financing | 1 | 2017 | 129 | 0.60 | Why? |
| Quality Control | 1 | 2019 | 628 | 0.60 | Why? |
| Environmental Policy | 1 | 2017 | 88 | 0.59 | Why? |
| Disaster Planning | 2 | 2019 | 1680 | 0.59 | Why? |
| Equipment and Supplies | 1 | 2020 | 440 | 0.59 | Why? |
| Hospital Administration | 2 | 2019 | 650 | 0.59 | Why? |
| Social Determinants of Health | 2 | 2017 | 1757 | 0.58 | Why? |
| Developed Countries | 5 | 2020 | 500 | 0.58 | Why? |
| Social Discrimination | 1 | 2019 | 269 | 0.57 | Why? |
| Cost Savings | 1 | 2017 | 296 | 0.57 | Why? |
| Mass Casualty Incidents | 1 | 2017 | 166 | 0.56 | Why? |
| Cardiovascular Diseases | 9 | 2019 | 11497 | 0.56 | Why? |
| Environmental Pollutants | 1 | 2019 | 320 | 0.56 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.54 | Why? |
| Mass Screening | 3 | 2018 | 8005 | 0.53 | Why? |
| Health Personnel | 7 | 2021 | 29646 | 0.53 | Why? |
| Cost of Illness | 4 | 2021 | 1903 | 0.53 | Why? |
| Healthcare Disparities | 4 | 2021 | 3893 | 0.52 | Why? |
| Suicide | 3 | 2017 | 1500 | 0.51 | Why? |
| Drug Costs | 1 | 2017 | 313 | 0.50 | Why? |
| Child Health Services | 2 | 2017 | 520 | 0.50 | Why? |
| Electronic Nicotine Delivery Systems | 2 | 2017 | 561 | 0.49 | Why? |
| Christianity | 1 | 2013 | 44 | 0.49 | Why? |
| Hospitals, Public | 1 | 2019 | 774 | 0.49 | Why? |
| International Agencies | 3 | 2020 | 202 | 0.49 | Why? |
| Economics | 3 | 2020 | 196 | 0.49 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.49 | Why? |
| Health Planning | 1 | 2020 | 607 | 0.49 | Why? |
| Pandemics | 43 | 2021 | 389249 | 0.49 | Why? |
| Cause of Death | 6 | 2020 | 4823 | 0.47 | Why? |
| Breast Neoplasms | 3 | 2018 | 3633 | 0.46 | Why? |
| Social Class | 4 | 2019 | 1360 | 0.46 | Why? |
| Public Health Practice | 1 | 2020 | 945 | 0.45 | Why? |
| Public Policy | 9 | 2020 | 1894 | 0.44 | Why? |
| Workplace | 3 | 2021 | 2075 | 0.44 | Why? |
| Financing, Government | 4 | 2021 | 434 | 0.44 | Why? |
| Climate Change | 1 | 2019 | 901 | 0.43 | Why? |
| Insurance, Health | 1 | 2017 | 634 | 0.43 | Why? |
| Vulnerable Populations | 3 | 2020 | 3099 | 0.43 | Why? |
| Pneumonia, Viral | 25 | 2020 | 243684 | 0.43 | Why? |
| Health Status Disparities | 5 | 2020 | 4072 | 0.43 | Why? |
| Hungary | 7 | 2021 | 491 | 0.43 | Why? |
| Coronavirus Infections | 25 | 2020 | 253789 | 0.42 | Why? |
| Socioeconomic Factors | 9 | 2018 | 8495 | 0.40 | Why? |
| History, 21st Century | 5 | 2019 | 1849 | 0.38 | Why? |
| Editorial Policies | 1 | 2014 | 408 | 0.37 | Why? |
| Tuberculosis | 3 | 2014 | 2895 | 0.36 | Why? |
| Delivery of Health Care, Integrated | 5 | 2017 | 1549 | 0.36 | Why? |
| Disasters | 1 | 2017 | 760 | 0.36 | Why? |
| Hospitals | 6 | 2019 | 11793 | 0.35 | Why? |
| Child Health | 1 | 2017 | 940 | 0.34 | Why? |
| Waste Water | 1 | 2018 | 2185 | 0.34 | Why? |
| Smoking | 8 | 2019 | 3358 | 0.34 | Why? |
| Internationality | 6 | 2021 | 3297 | 0.34 | Why? |
| Refugees | 1 | 2017 | 809 | 0.34 | Why? |
| Marketing | 2 | 2019 | 195 | 0.34 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.34 | Why? |
| Health | 2 | 2018 | 130 | 0.33 | Why? |
| Technology Assessment, Biomedical | 2 | 2019 | 106 | 0.33 | Why? |
| Crime | 2 | 2019 | 127 | 0.33 | Why? |
| Alcohol Drinking | 7 | 2019 | 1663 | 0.33 | Why? |
| Poverty | 1 | 2019 | 2302 | 0.33 | Why? |
| Housekeeping, Hospital | 2 | 2017 | 37 | 0.33 | Why? |
| Medical Staff, Hospital | 1 | 2017 | 1258 | 0.32 | Why? |
| Obesity | 6 | 2020 | 7388 | 0.32 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.32 | Why? |
| Social Media | 2 | 2019 | 5798 | 0.32 | Why? |
| Primary Health Care | 3 | 2021 | 4839 | 0.32 | Why? |
| Schools | 4 | 2021 | 4187 | 0.31 | Why? |
| Education | 1 | 2011 | 434 | 0.31 | Why? |
| Health Care Rationing | 1 | 2021 | 2558 | 0.31 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.30 | Why? |
| Wales | 3 | 2018 | 758 | 0.30 | Why? |
| Primary Prevention | 1 | 2013 | 778 | 0.30 | Why? |
| Surveys and Questionnaires | 9 | 2021 | 43792 | 0.30 | Why? |
| Information Dissemination | 2 | 2020 | 2986 | 0.30 | Why? |
| Costs and Cost Analysis | 3 | 2018 | 694 | 0.29 | Why? |
| Chronic Disease | 4 | 2020 | 5139 | 0.29 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.29 | Why? |
| United States | 16 | 2021 | 46150 | 0.29 | Why? |
| Periodicals as Topic | 2 | 2017 | 1492 | 0.28 | Why? |
| Attitude to Health | 1 | 2018 | 2002 | 0.28 | Why? |
| History, 20th Century | 4 | 2019 | 1282 | 0.28 | Why? |
| Pharmaceutical Preparations | 1 | 2019 | 1897 | 0.28 | Why? |
| Health Equity | 3 | 2021 | 1223 | 0.27 | Why? |
| Internet | 3 | 2019 | 6204 | 0.27 | Why? |
| Travel | 4 | 2021 | 7220 | 0.27 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.27 | Why? |
| Publishing | 1 | 2014 | 990 | 0.26 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.26 | Why? |
| Tobacco Smoking | 2 | 2018 | 349 | 0.25 | Why? |
| Antineoplastic Agents | 1 | 2019 | 3550 | 0.25 | Why? |
| World Health Organization | 4 | 2021 | 4213 | 0.24 | Why? |
| Betacoronavirus | 16 | 2020 | 204454 | 0.24 | Why? |
| Poisson Distribution | 2 | 2020 | 348 | 0.23 | Why? |
| Nurses | 1 | 2018 | 2285 | 0.23 | Why? |
| Mental Health | 4 | 2021 | 15770 | 0.23 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.23 | Why? |
| Multilevel Analysis | 2 | 2018 | 104 | 0.23 | Why? |
| Europe, Eastern | 2 | 2018 | 88 | 0.22 | Why? |
| Female | 48 | 2021 | 380317 | 0.22 | Why? |
| Ezetimibe, Simvastatin Drug Combination | 1 | 2020 | 6 | 0.22 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.22 | Why? |
| Social Mobility | 1 | 2021 | 54 | 0.22 | Why? |
| Contracts | 1 | 2021 | 49 | 0.21 | Why? |
| Physicians | 2 | 2020 | 4214 | 0.21 | Why? |
| Drug Approval | 2 | 2021 | 1325 | 0.21 | Why? |
| Educational Status | 3 | 2019 | 1451 | 0.21 | Why? |
| Emergency Medical Services | 1 | 2017 | 3557 | 0.21 | Why? |
| Communicable Disease Control | 8 | 2021 | 29620 | 0.21 | Why? |
| Government Employees | 1 | 2020 | 45 | 0.21 | Why? |
| Unemployment | 3 | 2018 | 702 | 0.20 | Why? |
| Health Priorities | 2 | 2020 | 959 | 0.20 | Why? |
| USSR | 1 | 2019 | 5 | 0.20 | Why? |
| Noncommunicable Diseases | 2 | 2021 | 934 | 0.20 | Why? |
| Vaccines | 1 | 2019 | 3692 | 0.20 | Why? |
| Homes for the Aged | 2 | 2020 | 1071 | 0.20 | Why? |
| Maternal-Child Health Services | 1 | 2021 | 124 | 0.20 | Why? |
| Substance-Related Disorders | 3 | 2019 | 2038 | 0.20 | Why? |
| Aquaculture | 1 | 2018 | 12 | 0.20 | Why? |
| Manure | 1 | 2018 | 25 | 0.19 | Why? |
| HIV Infections | 7 | 2017 | 11620 | 0.19 | Why? |
| Refugee Camps | 1 | 2020 | 62 | 0.19 | Why? |
| Slovakia | 1 | 2019 | 135 | 0.19 | Why? |
| Republic of Belarus | 4 | 2019 | 24 | 0.19 | Why? |
| Cellulose | 1 | 2019 | 106 | 0.19 | Why? |
| Cola | 1 | 2018 | 3 | 0.19 | Why? |
| Reimbursement, Incentive | 1 | 2019 | 70 | 0.19 | Why? |
| Qualitative Research | 4 | 2019 | 4337 | 0.19 | Why? |
| Water Pollutants | 1 | 2018 | 24 | 0.19 | Why? |
| Computers, Handheld | 1 | 2021 | 242 | 0.19 | Why? |
| Guidelines as Topic | 3 | 2021 | 2844 | 0.19 | Why? |
| Smoking Cessation | 2 | 2017 | 826 | 0.19 | Why? |
| Legislation, Hospital | 1 | 2018 | 24 | 0.18 | Why? |
| Lobbying | 1 | 2018 | 17 | 0.18 | Why? |
| Mental Disorders | 3 | 2021 | 6742 | 0.18 | Why? |
| Commonwealth of Independent States | 1 | 2017 | 1 | 0.18 | Why? |
| Kazakhstan | 1 | 2018 | 132 | 0.18 | Why? |
| Asia, Central | 1 | 2017 | 18 | 0.18 | Why? |
| Soil Pollutants | 1 | 2018 | 57 | 0.18 | Why? |
| Population Dynamics | 2 | 2020 | 378 | 0.18 | Why? |
| Social Values | 1 | 2019 | 109 | 0.18 | Why? |
| Interinstitutional Relations | 1 | 2020 | 170 | 0.18 | Why? |
| Legislation, Drug | 1 | 2019 | 101 | 0.18 | Why? |
| Patents as Topic | 1 | 2021 | 224 | 0.18 | Why? |
| Cost-Benefit Analysis | 2 | 2019 | 2259 | 0.18 | Why? |
| High Fructose Corn Syrup | 1 | 2017 | 5 | 0.18 | Why? |
| Caribbean Region | 1 | 2019 | 349 | 0.18 | Why? |
| Aging | 4 | 2021 | 3581 | 0.18 | Why? |
| Systems Integration | 1 | 2017 | 72 | 0.18 | Why? |
| Patient Safety | 1 | 2013 | 4885 | 0.18 | Why? |
| Social Responsibility | 2 | 2020 | 363 | 0.17 | Why? |
| Family Health | 2 | 2020 | 731 | 0.17 | Why? |
| Equipment and Supplies, Hospital | 1 | 2020 | 272 | 0.17 | Why? |
| Outsourced Services | 1 | 2016 | 4 | 0.17 | Why? |
| Male | 45 | 2021 | 367725 | 0.17 | Why? |
| Holidays | 1 | 2020 | 311 | 0.17 | Why? |
| Income | 4 | 2021 | 1564 | 0.17 | Why? |
| Armed Conflicts | 1 | 2021 | 209 | 0.17 | Why? |
| Fruit | 1 | 2019 | 313 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Syria | 1 | 2017 | 170 | 0.17 | Why? |
| Beverages | 1 | 2017 | 87 | 0.17 | Why? |
| Academic Success | 1 | 2017 | 75 | 0.16 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.16 | Why? |
| Sodium, Dietary | 1 | 2017 | 45 | 0.16 | Why? |
| Scientific Misconduct | 1 | 2019 | 101 | 0.16 | Why? |
| Health Status Indicators | 2 | 2017 | 341 | 0.16 | Why? |
| Aged | 30 | 2021 | 215776 | 0.16 | Why? |
| Federal Government | 2 | 2020 | 562 | 0.16 | Why? |
| Patient Acceptance of Health Care | 3 | 2021 | 5002 | 0.16 | Why? |
| Happiness | 1 | 2018 | 111 | 0.16 | Why? |
| Dissent and Disputes | 1 | 2018 | 117 | 0.16 | Why? |
| Oral Health | 1 | 2021 | 401 | 0.16 | Why? |
| United Nations | 3 | 2017 | 367 | 0.16 | Why? |
| Bullying | 1 | 2018 | 98 | 0.16 | Why? |
| Anniversaries and Special Events | 1 | 2017 | 127 | 0.16 | Why? |
| Sex Work | 1 | 2017 | 96 | 0.16 | Why? |
| Intersectoral Collaboration | 2 | 2021 | 1065 | 0.16 | Why? |
| Drugs, Investigational | 1 | 2019 | 198 | 0.16 | Why? |
| Health Status | 3 | 2021 | 3259 | 0.16 | Why? |
| Transportation | 2 | 2021 | 691 | 0.15 | Why? |
| Harm Reduction | 2 | 2019 | 392 | 0.15 | Why? |
| Child | 15 | 2021 | 70012 | 0.15 | Why? |
| Prisons | 2 | 2019 | 980 | 0.15 | Why? |
| Ownership | 1 | 2017 | 169 | 0.15 | Why? |
| Criminal Law | 1 | 2017 | 84 | 0.15 | Why? |
| Multimorbidity | 1 | 2021 | 703 | 0.15 | Why? |
| Urban Population | 4 | 2019 | 2000 | 0.15 | Why? |
| Awards and Prizes | 1 | 2017 | 101 | 0.15 | Why? |
| Hypertension | 5 | 2018 | 8895 | 0.15 | Why? |
| Plastics | 1 | 2019 | 463 | 0.15 | Why? |
| Gambling | 1 | 2019 | 183 | 0.15 | Why? |
| Patient Advocacy | 1 | 2017 | 173 | 0.15 | Why? |
| Antihypertensive Agents | 2 | 2018 | 1962 | 0.15 | Why? |
| Focus Groups | 1 | 2019 | 811 | 0.15 | Why? |
| Middle Aged | 35 | 2021 | 270681 | 0.15 | Why? |
| Community Health Workers | 1 | 2020 | 468 | 0.15 | Why? |
| Stress, Psychological | 1 | 2019 | 10231 | 0.15 | Why? |
| Myocardial Revascularization | 1 | 2017 | 267 | 0.15 | Why? |
| Emergencies | 2 | 2021 | 4095 | 0.14 | Why? |
| Water Purification | 1 | 2018 | 285 | 0.14 | Why? |
| Rare Diseases | 1 | 2019 | 373 | 0.14 | Why? |
| Plants, Toxic | 1 | 2014 | 4 | 0.14 | Why? |
| Lebanon | 1 | 2017 | 557 | 0.14 | Why? |
| Binge Drinking | 1 | 2015 | 60 | 0.14 | Why? |
| Health Services Research | 2 | 2019 | 756 | 0.14 | Why? |
| Health Behavior | 3 | 2018 | 4449 | 0.14 | Why? |
| Triglycerides | 1 | 2017 | 478 | 0.14 | Why? |
| Death | 1 | 2017 | 334 | 0.14 | Why? |
| Civil Defense | 3 | 2021 | 1687 | 0.14 | Why? |
| Hope | 1 | 2017 | 210 | 0.14 | Why? |
| Muscle Strength | 1 | 2017 | 317 | 0.14 | Why? |
| Policy | 2 | 2021 | 1372 | 0.14 | Why? |
| Alcohols | 1 | 2015 | 86 | 0.14 | Why? |
| Capacity Building | 1 | 2020 | 683 | 0.13 | Why? |
| Bangladesh | 1 | 2020 | 1620 | 0.13 | Why? |
| Health Care Sector | 1 | 2017 | 191 | 0.13 | Why? |
| Ethanol | 1 | 2019 | 533 | 0.13 | Why? |
| Rural Population | 4 | 2019 | 2408 | 0.13 | Why? |
| Psychotropic Drugs | 1 | 2018 | 396 | 0.13 | Why? |
| Logistic Models | 4 | 2019 | 9089 | 0.13 | Why? |
| Disclosure | 1 | 2018 | 423 | 0.13 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.13 | Why? |
| Adolescent | 17 | 2021 | 86841 | 0.12 | Why? |
| Phagocytosis | 1 | 2015 | 409 | 0.12 | Why? |
| Research Design | 3 | 2018 | 5830 | 0.12 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.12 | Why? |
| Smokers | 1 | 2018 | 550 | 0.12 | Why? |
| Patient-Centered Care | 1 | 2021 | 860 | 0.12 | Why? |
| Ireland | 1 | 2018 | 1456 | 0.12 | Why? |
| Sex Workers | 1 | 2017 | 348 | 0.12 | Why? |
| Information Seeking Behavior | 1 | 2019 | 539 | 0.12 | Why? |
| Risk Factors | 10 | 2021 | 71621 | 0.12 | Why? |
| Program Development | 1 | 2018 | 1089 | 0.12 | Why? |
| Models, Theoretical | 1 | 2011 | 6659 | 0.12 | Why? |
| Myocardial Infarction | 2 | 2018 | 3361 | 0.11 | Why? |
| Israel | 1 | 2021 | 2751 | 0.11 | Why? |
| Population Surveillance | 3 | 2020 | 4967 | 0.11 | Why? |
| Alcoholism | 2 | 2011 | 691 | 0.11 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.11 | Why? |
| Alcohol Dehydrogenase | 1 | 2011 | 19 | 0.11 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.11 | Why? |
| Government Regulation | 1 | 2018 | 842 | 0.11 | Why? |
| Protective Factors | 1 | 2017 | 1720 | 0.11 | Why? |
| Search Engine | 1 | 2019 | 628 | 0.11 | Why? |
| Motion Pictures | 1 | 2011 | 62 | 0.11 | Why? |
| Mining | 1 | 2011 | 32 | 0.11 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.11 | Why? |
| Aged, 80 and over | 13 | 2021 | 88759 | 0.11 | Why? |
| Canada | 3 | 2019 | 6018 | 0.11 | Why? |
| Counseling | 1 | 2017 | 747 | 0.11 | Why? |
| Adult | 27 | 2021 | 244371 | 0.11 | Why? |
| Alcohol-Related Disorders | 1 | 2011 | 84 | 0.11 | Why? |
| Risk Reduction Behavior | 1 | 2018 | 946 | 0.11 | Why? |
| Spain | 2 | 2020 | 15545 | 0.10 | Why? |
| Age Distribution | 2 | 2018 | 3567 | 0.10 | Why? |
| Prisoners | 1 | 2019 | 738 | 0.10 | Why? |
| Epidemics | 1 | 2011 | 6407 | 0.10 | Why? |
| Poland | 1 | 2018 | 2368 | 0.10 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.10 | Why? |
| Stents | 1 | 2017 | 916 | 0.10 | Why? |
| Greece | 1 | 2016 | 2091 | 0.10 | Why? |
| Young Adult | 14 | 2021 | 93724 | 0.10 | Why? |
| Prevalence | 7 | 2021 | 25773 | 0.10 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.10 | Why? |
| Electronic Health Records | 2 | 2021 | 3492 | 0.10 | Why? |
| Interprofessional Relations | 1 | 2017 | 1013 | 0.10 | Why? |
| Data Collection | 1 | 2019 | 1769 | 0.10 | Why? |
| Diffusion of Innovation | 1 | 2013 | 440 | 0.09 | Why? |
| Adolescent Behavior | 1 | 2015 | 400 | 0.09 | Why? |
| Sports | 1 | 2017 | 690 | 0.09 | Why? |
| Forecasting | 2 | 2021 | 4492 | 0.09 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.09 | Why? |
| Feeding and Eating Disorders | 1 | 2015 | 525 | 0.09 | Why? |
| Interviews as Topic | 3 | 2017 | 1952 | 0.09 | Why? |
| Employment | 2 | 2017 | 1754 | 0.09 | Why? |
| Health Communication | 1 | 2019 | 1120 | 0.09 | Why? |
| Long-Term Care | 1 | 2020 | 2047 | 0.09 | Why? |
| Accidents, Traffic | 1 | 2013 | 464 | 0.09 | Why? |
| Australia | 2 | 2018 | 6306 | 0.08 | Why? |
| Staphylococcal Infections | 1 | 2016 | 1099 | 0.08 | Why? |
| Needs Assessment | 1 | 2017 | 2352 | 0.08 | Why? |
| Health Promotion | 2 | 2017 | 2020 | 0.08 | Why? |
| Hypersensitivity | 1 | 2017 | 1137 | 0.08 | Why? |
| Geography, Medical | 2 | 2021 | 537 | 0.08 | Why? |
| Vaccination Coverage | 1 | 2016 | 1249 | 0.08 | Why? |
| Drug and Narcotic Control | 2 | 2019 | 134 | 0.08 | Why? |
| Family Characteristics | 1 | 2017 | 2551 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.08 | Why? |
| Homeless Persons | 1 | 2017 | 1171 | 0.08 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.08 | Why? |
| Health Services Needs and Demand | 2 | 2020 | 3419 | 0.08 | Why? |
| End Stage Liver Disease | 1 | 2011 | 418 | 0.08 | Why? |
| Cross-Sectional Studies | 9 | 2021 | 53120 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2017 | 2218 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.07 | Why? |
| Clinical Competence | 1 | 2020 | 3263 | 0.07 | Why? |
| Behavior Therapy | 1 | 2008 | 235 | 0.07 | Why? |
| Research | 1 | 2018 | 2115 | 0.07 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.07 | Why? |
| Sleep | 1 | 2017 | 2695 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Maternal Health Services | 1 | 2013 | 808 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.06 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.06 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.06 | Why? |
| Occupational Stress | 1 | 2017 | 2044 | 0.06 | Why? |
| Diabetes Mellitus | 2 | 2018 | 8207 | 0.06 | Why? |
| Respiratory Tract Diseases | 1 | 2011 | 1061 | 0.06 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| New Zealand | 2 | 2020 | 2073 | 0.06 | Why? |
| Monocytes | 1 | 2015 | 2978 | 0.06 | Why? |
| Africa | 1 | 2011 | 2986 | 0.06 | Why? |
| Neoplasms | 3 | 2018 | 17251 | 0.06 | Why? |
| Congresses as Topic | 1 | 2011 | 1347 | 0.06 | Why? |
| Industrial Development | 1 | 2020 | 29 | 0.06 | Why? |
| Environment | 2 | 2018 | 769 | 0.05 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.05 | Why? |
| Far East | 1 | 2020 | 125 | 0.05 | Why? |
| Sex Distribution | 2 | 2018 | 2083 | 0.05 | Why? |
| Renal Circulation | 1 | 2020 | 44 | 0.05 | Why? |
| Diet | 1 | 2013 | 2052 | 0.05 | Why? |
| Mental Health Services | 1 | 2017 | 3007 | 0.05 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.05 | Why? |
| Political Activism | 1 | 2020 | 50 | 0.05 | Why? |
| Food Labeling | 1 | 2018 | 18 | 0.05 | Why? |
| Regression Analysis | 2 | 2017 | 2484 | 0.05 | Why? |
| Health Systems Agencies | 1 | 2018 | 12 | 0.05 | Why? |
| Health Information Exchange | 1 | 2020 | 151 | 0.05 | Why? |
| Consumer Health Informatics | 1 | 2019 | 57 | 0.05 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.05 | Why? |
| Kyrgyzstan | 1 | 2017 | 7 | 0.04 | Why? |
| Databases as Topic | 1 | 2018 | 103 | 0.04 | Why? |
| Sulfonylurea Compounds | 1 | 2018 | 79 | 0.04 | Why? |
| Social Control, Formal | 1 | 2020 | 165 | 0.04 | Why? |
| Case Managers | 1 | 2017 | 25 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Americas | 1 | 2019 | 418 | 0.04 | Why? |
| Diet, Sodium-Restricted | 1 | 2017 | 23 | 0.04 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.04 | Why? |
| Food Analysis | 1 | 2017 | 53 | 0.04 | Why? |
| Interrupted Time Series Analysis | 1 | 2021 | 868 | 0.04 | Why? |
| Child, Preschool | 5 | 2020 | 36283 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Mortality, Premature | 1 | 2018 | 111 | 0.04 | Why? |
| Administrative Personnel | 1 | 2020 | 326 | 0.04 | Why? |
| Medically Uninsured | 1 | 2018 | 237 | 0.04 | Why? |
| Residence Characteristics | 2 | 2018 | 1927 | 0.04 | Why? |
| Geographic Information Systems | 1 | 2020 | 507 | 0.04 | Why? |
| Public Health Surveillance | 2 | 2021 | 3129 | 0.04 | Why? |
| Patient Protection and Affordable Care Act | 1 | 2018 | 164 | 0.04 | Why? |
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 92 | 0.04 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.04 | Why? |
| Network Meta-Analysis | 1 | 2018 | 426 | 0.04 | Why? |
| Computer Simulation | 1 | 2011 | 4982 | 0.04 | Why? |
| Africa, Western | 1 | 2016 | 363 | 0.04 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.04 | Why? |
| Poliovirus Vaccine, Oral | 1 | 2016 | 95 | 0.04 | Why? |
| Economics, Hospital | 1 | 2016 | 97 | 0.04 | Why? |
| Public-Private Sector Partnerships | 1 | 2018 | 259 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.04 | Why? |
| Longitudinal Studies | 3 | 2017 | 9893 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.04 | Why? |
| Social Support | 2 | 2021 | 3183 | 0.04 | Why? |
| Budgets | 1 | 2017 | 155 | 0.04 | Why? |
| Population Density | 1 | 2020 | 694 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.04 | Why? |
| Security Measures | 1 | 2017 | 211 | 0.04 | Why? |
| Infant | 4 | 2020 | 30274 | 0.03 | Why? |
| Volunteers | 1 | 2020 | 601 | 0.03 | Why? |
| Cognition Disorders | 1 | 2020 | 574 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Cholesterol, HDL | 1 | 2017 | 439 | 0.03 | Why? |
| Air Pollution | 1 | 2013 | 3504 | 0.03 | Why? |
| Iatrogenic Disease | 1 | 2016 | 304 | 0.03 | Why? |
| Heart Diseases | 1 | 2011 | 3503 | 0.03 | Why? |
| Tobacco Use | 1 | 2017 | 340 | 0.03 | Why? |
| Cohort Studies | 4 | 2018 | 36005 | 0.03 | Why? |
| Malaysia | 1 | 2018 | 1116 | 0.03 | Why? |
| Causality | 1 | 2017 | 857 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2021 | 1357 | 0.03 | Why? |
| Drug Users | 1 | 2017 | 234 | 0.03 | Why? |
| Algorithms | 1 | 2011 | 7346 | 0.03 | Why? |
| Colombia | 1 | 2018 | 1241 | 0.03 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2016 | 282 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Immunity, Herd | 1 | 2020 | 1011 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2018 | 693 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Patients' Rooms | 1 | 2017 | 675 | 0.03 | Why? |
| Ageism | 1 | 2018 | 361 | 0.03 | Why? |
| Information Storage and Retrieval | 1 | 2017 | 644 | 0.03 | Why? |
| Morals | 1 | 2017 | 483 | 0.03 | Why? |
| Belgium | 1 | 2018 | 2064 | 0.03 | Why? |
| Metformin | 1 | 2018 | 640 | 0.03 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.03 | Why? |
| Liver Function Tests | 1 | 2017 | 1325 | 0.03 | Why? |
| Linkage Disequilibrium | 1 | 2011 | 191 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.03 | Why? |
| Frail Elderly | 1 | 2020 | 1427 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 711 | 0.03 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.02 | Why? |
| Cooperative Behavior | 1 | 2017 | 1216 | 0.02 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.02 | Why? |
| Factor Analysis, Statistical | 1 | 2011 | 538 | 0.02 | Why? |
| Patients | 1 | 2017 | 1167 | 0.02 | Why? |
| Retirement | 1 | 2009 | 157 | 0.02 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Cities | 1 | 2020 | 4937 | 0.02 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2021 | 2517 | 0.02 | Why? |
| Stroke | 1 | 2011 | 8839 | 0.02 | Why? |
| Genetic Association Studies | 1 | 2011 | 559 | 0.02 | Why? |
| Iran | 1 | 2020 | 5467 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Men's Health | 1 | 2008 | 80 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.02 | Why? |
| Perception | 1 | 2018 | 2827 | 0.02 | Why? |
| BCG Vaccine | 1 | 2016 | 1137 | 0.02 | Why? |
| Eligibility Determination | 1 | 2008 | 255 | 0.02 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Organizational Case Studies | 1 | 2006 | 293 | 0.02 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.02 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.02 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Cells, Cultured | 1 | 2015 | 5835 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Racism | 1 | 2016 | 1462 | 0.02 | Why? |
| Base Sequence | 1 | 2011 | 3581 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2011 | 2830 | 0.01 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.01 | Why? |
| Survival Analysis | 1 | 2014 | 7592 | 0.01 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2011 | 5440 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Genotype | 1 | 2011 | 4697 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2011 | 3607 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.01 | Why? |
| Clinical Protocols | 1 | 2008 | 2734 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Patient Selection | 1 | 2008 | 4560 | 0.01 | Why? |
| Case-Control Studies | 1 | 2011 | 17671 | 0.01 | Why? |
| Quality of Life | 1 | 2009 | 9820 | 0.01 | Why? |